Nova Leap Health Corp. provides home and home health care services. More Details
Fair value with mediocre balance sheet.
Share Price & News
How has Nova Leap Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NLH is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: NLH's weekly volatility (6%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: NLH exceeded the Canadian Healthcare industry which returned 44.1% over the past year.
Return vs Market: NLH exceeded the Canadian Market which returned 37.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Nova Leap Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StNova Leap Health (CVE:NLH) Strong Profits May Be Masking Some Underlying Issues
5 months ago | Simply Wall StHow Much is Nova Leap Health's (CVE:NLH) CEO Getting Paid?
7 months ago | Simply Wall StIs Nova Leap Health (CVE:NLH) A Risky Investment?
Is Nova Leap Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NLH (CA$0.76) is trading below our estimate of fair value (CA$1.31)
Significantly Below Fair Value: NLH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NLH is poor value based on its PE Ratio (32.3x) compared to the CA Healthcare industry average (25.4x).
PE vs Market: NLH is poor value based on its PE Ratio (32.3x) compared to the Canadian market (16.1x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NLH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NLH is good value based on its PB Ratio (4.2x) compared to the CA Healthcare industry average (4.6x).
How is Nova Leap Health forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NLH's forecast earnings growth is above the savings rate (1.5%).
Earnings vs Market: Insufficient data to determine if NLH's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NLH's revenue (23.3% per year) is forecast to grow faster than the Canadian market (7.3% per year).
High Growth Revenue: NLH's revenue (23.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NLH's Return on Equity is forecast to be high in 3 years time
How has Nova Leap Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NLH has a large one-off gain of $1.2M impacting its December 31 2020 financial results.
Growing Profit Margin: NLH became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: NLH has become profitable over the past 5 years, growing earnings by 20.9% per year.
Accelerating Growth: NLH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: NLH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (97.3%).
Return on Equity
High ROE: NLH's Return on Equity (12.8%) is considered low.
How is Nova Leap Health's financial position?
Financial Position Analysis
Short Term Liabilities: NLH's short term assets ($4.3M) exceed its short term liabilities ($4.2M).
Long Term Liabilities: NLH's short term assets ($4.3M) exceed its long term liabilities ($3.5M).
Debt to Equity History and Analysis
Debt Level: NLH's debt to equity ratio (56.6%) is considered high.
Reducing Debt: Insufficient data to determine if NLH's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: NLH's debt is well covered by operating cash flow (54%).
Interest Coverage: Insufficient data to determine if NLH's interest payments on its debt are well covered by EBIT.
What is Nova Leap Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NLH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NLH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NLH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NLH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NLH's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Chris Dobbin (45 yo)
Mr. Christopher Donald Dobbin, also known as Chris, CPA, CA, serves as the Chief Executive Officer and President of Nova Leap Health Corp. and served as its Chief Financial Officer until October 2016. Mr. ...
CEO Compensation Analysis
Compensation vs Market: Chris's total compensation ($USD247.21K) is above average for companies of similar size in the Canadian market ($USD156.68K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
Experienced Board: NLH's board of directors are considered experienced (3.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: NLH insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.4%.
Nova Leap Health Corp.'s company bio, employee growth, exchange listings and data sources
- Name: Nova Leap Health Corp.
- Ticker: NLH
- Exchange: TSXV
- Founded: 2015
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$53.316m
- Shares outstanding: 70.15m
- Website: https://novaleaphealth.com
- Nova Leap Health Corp.
- 7071 Bayers Road
- Suite 5003
- Nova Scotia
- B3L 2C2
Nova Leap Health Corp. provides home and home health care services. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, daily living, light housekeep...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/06 23:40|
|End of Day Share Price||2021/05/06 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.